S. Korea Panel Recommends Restricting Painkillers To 15 And Older
This article was originally published in PharmAsia News
Executive Summary
South Korea's drug regulator is expected to accept a recommendation that certain painkillers be restricted to persons 15 years of age and older. Among the drugs on a list drafted by the Central Pharmaceutical Affairs Council were popular medicines such as Bayer Korea's Saridon-A and Samjin Pharm's Geworin because their active pharmaceutical ingredient is isopropylantipyrine. The council said in its recommendation to the South Korea FDA the drug can cause heart disorders and loss of consciousness and should not be available to people under the age of 15. (Click here for more